Boc-Leu-Gly-Arg-AMC

Boc-Leu-Gly-Arg-AMC is a fluorogenic AMC substrate for the convertases. Boc-Leu-Gly-Arg-AMC can be used in enzymatic assays.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Boc-Leu-Gly-Arg-AMC(CAS 65147-09-3)

CAT No: 10-101-299

CAS No:65147-09-3

Synonyms/Alias:Boc-Leu-Gly-Arg-AMC;65147-09-3;Boc-Leu-Gly-Arg-Mca;tert-butyl N-[(2S)-1-[[2-[[(2S)-5-(diaminomethylideneamino)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]carbamate;BOC-LEU-GLY-ARG-AMC ACETATE SALT;HY-P2237;AKOS040764220;DA-71642;FB110486;MS-30623;Boc-Leu-Gly-Arg-4-methyl-coumaryl-7-amide;CS-0114663;G12102;tert-butyl ((S)-1-((2-(((S)-5-guanidino-1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxopentan-2-yl)amino)-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)carbamate;tert-butyl (S)-1-(2-((S)-5-guanidino-1-(4-methyl-2-oxo-2H-chromen-7-ylamino)-1-oxopentan-2-ylamino)-2-oxoethylamino)-4-methyl-1-oxopentan-2-ylcarbamate;

Chemical Name:tert-butyl N-[(2S)-1-[[2-[[(2S)-5-(diaminomethylideneamino)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]carbamate

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C29H43N7O7
M.W/Mr.
601.7
Sequence
One Letter Code:LGR
Three Letter Code:Boc-Leu-Gly-Arg-AMC

Boc-Leu-Gly-Arg-AMC is a specialized peptide substrate widely recognized for its utility in biochemical and enzymatic research. Comprising a sequence of N-tert-butyloxycarbonyl-leucyl-glycyl-arginine linked to 7-amino-4-methylcoumarin (AMC), this compound offers both structural specificity and a fluorogenic reporter, making it invaluable for detecting proteolytic activity. The presence of the AMC moiety enables sensitive fluorescence-based assays, allowing for precise quantification of enzymatic cleavage events. Its peptide backbone is carefully designed to mimic natural substrates, ensuring compatibility with a variety of proteases, particularly those with trypsin-like specificity. Researchers benefit from its high solubility in aqueous buffers and its stability under standard laboratory conditions, facilitating consistent and reproducible results across different experimental setups.

Protease Activity Assays: Boc-Leu-Gly-Arg-AMC is extensively utilized in the assessment of serine protease activity, particularly for enzymes such as trypsin and related proteases. Upon enzymatic cleavage at the arginine residue, the AMC group is released, resulting in a measurable fluorescent signal. This property enables real-time monitoring of enzymatic reactions, making the substrate ideal for kinetic studies, inhibitor screening, and enzyme characterization. The sensitivity of the fluorescence detection allows for the quantification of even low levels of protease activity, supporting detailed enzymological investigations.

Enzyme Kinetics Studies: The substrate's design is particularly advantageous for detailed kinetic analyses of proteolytic enzymes. By providing a well-defined cleavage site and a robust fluorescent readout, it facilitates the determination of kinetic parameters such as Km and Vmax. Researchers can use it to compare the catalytic efficiency of wild-type versus mutant enzymes or to investigate the effects of various cofactors and environmental conditions on protease function. The rapid and continuous readout afforded by the AMC fluorophore streamlines data collection, enhancing throughput and experimental accuracy.

High-Throughput Screening: In drug discovery and inhibitor development, Boc-Leu-Gly-Arg-AMC serves as a reliable tool for high-throughput screening of compound libraries. Its compatibility with multi-well plate formats and automated fluorescence detection systems enables the rapid evaluation of thousands of samples in parallel. This accelerates the identification of potential protease inhibitors or activators, contributing to the early stages of therapeutic development. The substrate's specificity reduces background noise and false positives, increasing the efficiency and reliability of screening campaigns.

Biological Pathway Elucidation: The peptide substrate is also instrumental in dissecting proteolytic pathways within complex biological samples. By selectively measuring the activity of specific proteases, researchers can map enzymatic cascades involved in physiological and pathological processes. Its application extends to cell lysates, tissue extracts, and recombinant systems, where it helps unravel the roles of individual proteases in diverse biological contexts. The ability to monitor proteolytic events in real time aids in understanding regulatory mechanisms and potential intervention points in signaling pathways.

Structure-Activity Relationship (SAR) Studies: Boc-Leu-Gly-Arg-AMC is frequently employed in SAR studies aimed at optimizing peptide substrates or inhibitors. By systematically modifying the peptide sequence and assessing changes in enzymatic cleavage, researchers can identify key structural determinants of substrate recognition and catalysis. The fluorogenic nature of the substrate allows for rapid and quantitative assessment of activity, supporting iterative design and refinement of bioactive molecules. This application is particularly valuable in the context of rational drug design and the development of targeted molecular probes.

In summary, Boc-Leu-Gly-Arg-AMC stands out as a versatile and sensitive tool for a wide range of research applications, from fundamental enzymology to advanced drug discovery. Its unique combination of peptide specificity and fluorogenic detection empowers researchers to probe protease function, screen for modulators, and elucidate complex biological pathways with precision and efficiency. The substrate's adaptability to various assay formats and experimental conditions further enhances its value in both academic and industrial laboratories, supporting innovative advances in biochemical research.

Source#
Synthetic
Long-term Storage Conditions
10 mM in DMSO
Shipping Condition
+20°C (International: -20°C)
InChI
InChI=1S/C29H43N7O7/c1-16(2)12-21(36-28(41)43-29(4,5)6)25(39)33-15-23(37)35-20(8-7-11-32-27(30)31)26(40)34-18-9-10-19-17(3)13-24(38)42-22(19)14-18/h9-10,13-14,16,20-21H,7-8,11-12,15H2,1-6H3,(H,33,39)(H,34,40)(H,35,37)(H,36,41)(H4,30,31,32)/t20-,21-/m0/s1
InChI Key
DLAQYOHJZUTWDJ-SFTDATJTSA-N
Canonical SMILES
CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)C(CCCN=C(N)N)NC(=O)CNC(=O)C(CC(C)C)NC(=O)OC(C)(C)C
Isomeric SMILES
CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)OC(C)(C)C

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Epitope Mapping ServicesPeptide Analysis ServicesCustom Conjugation ServicePeptide CDMOPeptide Synthesis ServicescGMP Peptide ServicePeptide Nucleic Acids SynthesisPeptide Modification Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers